Pfizer announced on Tuesday that it had requested emergency authorization in the United States for its anti-Covid pill, a highly anticipated treatment because it can easily be taken at home in the first days after the onset of symptoms in the event of an infection.
Read also Anti-Covid pills: the battle is brewing between the American MSD and Pfizer labs
The pharmaceutical giant has filed its request for this antiviral treatment with the United States Medicines Agency (FDA), he said in a statement.
